aceArtificial intelligence assisted genomic profiling of ovarian cancer liver metastases
Liver involvement in ovarian cancer is often treated as a single clinical entity, although liver-surface implants and parenchymal deposits occupy different anatomical settings and may not share the same molecular history. Primary-tumor profiling is informative, but can miss lesion-specific evolution, treatment-associated cell states, and microenvironmental structure. This Mini Review examines how germline susceptibility, somatic change, spatial biology, and artificial intelligence might be combined in high-grade…
Direct molecular evidence from hepatic lesions in ovarian cancer is sparse, so AI-based integration cannot yet be used to select liver-directed therapy or influence patient management.
The source states that direct molecular evidence from hepatic lesions is sparse and that AI integration is not a validated route to select liver-directed therapy, so clinical use awaits further validation.
Evidence
- Peer-reviewedFrontiers in Genetics2026-10-20
How should this claim be treated?
Truvace Impact Record TRV-2026-1998, v1: “Artificial intelligence assisted genomic profiling of ovarian cancer liver metastases.” Truvace, 2026-10-20. /record/TRV-2026-1998 (accessed at citation time). sha256 c6a95e0780132633…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1998 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.